BNC-101

• UNSPSC Description:

  BNC-101 is a human-derived antibody expressed in CHO cells that targets GPR49/LGR5. The predicted molecular weight (MW) of BNC-101 is 150 kDa. The isotype control for BNC-101 can refer to Human IgG1 kappa, Isotype Control (HY-P99001).

• Target Antigen:

  Others

• Type:

  Inhibitory Antibodies

• Related Pathways:

  Others

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/bnc-101.html

• Shipping Conditions:

  Room temperature

• Clinical Information:

  Phase 1